Based in Riom in the Puy-de-Dôme region of France, Verdot IPS² designs and manufactures a complete range of purification equipment for the biopharmaceutical, pharmaceutical, cosmetics and food industries (mainly chromatography columns and skids), a critical technology for the development and production of active ingredients for drugs, vaccines and biotech products. Its customers are mainly major players in the pharmaceutical industry (Top 10 big pharma & subcontractors, French and international biotechs).
Very few players in the world have mastered this cutting-edge technology, and are in a position to meet the highly demanding regulatory specifications of pharmaceutical product certification processes. The company has developed unique expertise, know-how and agility in terms of responding to complex calls for tender (customized equipment) and production lead-times, a key factor in the current context of very tight demand.
With average annual growth of 15% since 2015, Verdot IPS² will achieve sales of around €13.5 million in 2020, of which almost 90% will be generated internationally, and employs 40 staff, including nearly 20 engineers. With the support of Capital Export, Verdot IPS²'s strategy is to pursue the development of its product range and accelerate its international deployment, particularly in China and North America, while continuing its efforts to diversify by sector.
Capital Export will also support its new shareholding in further developing its ESG policy. This approach is an integral part of the company's strategy, which is already well advanced in the implementation and monitoring of extra-financial issues (training, quality, safety of human resources, use of resources and environmental impact).
.png)
